Search results
Results from the Health.Zone Content Network
The Electronic Vaccination Data System ( EVDS) is a digital platform developed by the National Department of Health of the South African government to manage the country's COVID-19 vaccination program. Enrolment is currently available for everyone over the age of 12 [3] and the platform can also generate a digital vaccine certificate.
Digital Vaccine Card Used in South Africa (Version 2) Current South African COVID-19 Vaccination Record Cards Contain Identification information and provision for 3 doses of vaccines. The eVaccine Card or Digital Vaccine Certificates can be assessed at https://vaccine.certificate.health.gov.za/ Archived 2021-10-17 at the Wayback Machine
On 17 February 2021, South Africa started its national vaccination program against COVID-19. The program will go through in phases, prioritizing healthcare and frontline workers and then those over the age of 60. According to health officials, South Africa has administered 38,717,957 vaccine doses across the country as of 27 March 2023.
An International Certificate of Vaccination or Revaccination Against Yellow Fever, issued in the Soviet Union in 1985. The International Certificate of Inoculation and Vaccination was established by the International Sanitary Convention for Aerial Navigation (1933) in The Hague, which came into force on 1 August 1935 and was amended in 1944. [3]
COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country . Eswatini began its vaccination program on 19 March 2021.
SMART Health Card. The SMART Health Card framework is an open source [1] immunity passport program designed to store and share medical information in paper or digital form. [2] It was initially launched as a vaccine passport during the COVID-19 pandemic, but is envisioned for use for other infectious diseases. [3]
The National Advisory Group on Immunization ( NAGI ), in South Africa, established in 1993 advises the National Department of Health on issues pertinent to vaccination and infectious diseases. It makes recommendations on vaccine formulations and vaccination schedules. [1] [2] [3]
ARCoV is an mRNA vaccine which consists of lipid nanoparticle–encapsulated mRNA encoding the receptor binding domain of SARS-CoV-2. It was the first mRNA vaccine to be approved for clinical trials in China. Manufactured as a liquid, ARCoV is thermostable at room temperature for at least 1 week.